Skip to main content
. 2023 Nov 16;11(32):7814–7821. doi: 10.12998/wjcc.v11.i32.7814

Table 3.

Secondary outcomes

Outcome
Aspirin group (n = 30)
No aspirin group (n = 30)
P value
mRS score at 90 d, median (IQR) 2 (1-3) 3 (2-4) 0.04
Bleeding complications, n (%) 2 (6.7) 2 (6.7) 1.00
Intracranial hemorrhage, n (%) 0 (0) 0 (0) -
Gastrointestinal bleeding, n (%) 0 (0) 0 (0) -
Other major bleeding, n (%) 2 (6.7) 2 (6.7) -
Mortality rate, n (%) 3 (10) 4 (13.3) 0.69

IQR: Interquartile range; mRS: Modified Rankin Scale.